Edition 40 – The Evolution of WHIMS – What Healthcare Organizations Can Learn from Its Genesis, Development, and Future Potential
The Evolution of WHIMS – What Healthcare Organizations can learn from its genesis, development, and future potential By Dr Nadeem Ahmed, Gabriel Oke Share on facebook Facebook Share on twitter Twitter Share on linkedin LinkedIn Citation Ahmed N and Oke G. The evolution of WHIMS – What healthcare organizations can learn from its genesis, development, […]
Edition 40 – The Impact of Remote Recruitment and Intervention on Adolescents At-Risk for Cybervictimization
The Impact of Remote Recruitment and Intervention on Adolescents At-Risk for Cybervictimization By Chiaka Ibe, Megan Ranney, MD, MPH, FACEP; John Pateña, MPH, MA; Tyler Wray, PhD, Brown University Share on facebook Facebook Share on twitter Twitter Share on linkedin LinkedIn Citation Ibe C, Ranney M, Pateña J, Wray T. The impact of remote recruitment […]
Edition 40 – Are We Ready for Telerehabilitation to Become Mainstream? Opinion About Upper Extremity Orthopedic Conditions
Are We Ready for Telerehabilitation to Become Mainstream? Opinion About Upper Extremity Orthopedic Conditions By Thierry Lienou, OTD, OTR/L, CAPS, ATP Facebook Twitter LinkedIn Citation Lienou T. Are we reaady for telerehabilitation to become mainstream? Opinion about upper extremity orthopediuc conditions. HPHR. 2021;40. DOI:10.54111/0001/NN3 Are we ready for telerehabilitation to become mainstream? Opinion about […]
Edition 40 – AI to Transform the Drug Approval Process and De-Risk Drug Development
AI to Transform the Drug Approval Process and De-Risk Drug Development By Cherubin Manokaran Facebook Twitter LinkedIn Citation Manokaran C. AI to transform the drug approval process and de-risk drug development. HPHR. 2021;40. 10.54111/0001/NN4 AI to Transform the Drug Approval Process and De-risk Drug Development Abstract The public tends to view high drug prices through […]
